Tirzepatide is a prescription medicine that acts on two gut hormone receptors, GIP and GLP-1, which are involved in appetite and blood sugar regulation. It is sold in Australia under the brand name Mounjaro and is TGA registered.
Tirzepatide is prescription only. It is not suitable for everyone, and a doctor assesses medical history, current medications and individual circumstances before it is considered as part of a broader weight management or metabolic health plan.